Company / Manufacturer Landing Page
Aequus Pharmaceuticals
Default labeling landing page · 4 products across 2 product families
GS1 GCP 9506000aequus.health
🏛️Welcome
You have reached the default landing page for Aequus Pharmaceuticals. The code you scanned could not be matched to a specific product, so we are showing our full product directory below.
Aequus Pharmaceuticals maintains electronic patient information leaflets for the following products across 2 product families: QLP9 C10.
💊All products
| GTIN | Brand | Family | Strength | Dose form | Market | Leaflet |
|---|---|---|---|---|---|---|
| 9506000183909 | Qulipta | QLP9 | 15 mg | Single-dose injectable | US | Open → |
| 9506000183916 | Qulipta | QLP9 | 25 mg | Single-dose injectable | US | Open → |
| 9506000183923 | Cardex | C10 | 10 mg | Solid oral dose | US | Open → |
| 9506000183930 | Cardex | C10 | 10 mg | Solid oral dose | EU | Open → |
Need the full prescribing information?
The complete, regulator-approved information is available via the official Aequus labeling disclaimer.
View General Disclaimer & Full Prescribing Information →